Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 840

Similar articles for PubMed (Select 18848318)

1.

A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome.

Kim EC, Choi JS, Joo CK.

Am J Ophthalmol. 2009 Feb;147(2):206-213.e3. doi: 10.1016/j.ajo.2008.08.015. Epub 2008 Oct 9.

PMID:
18848318
2.

Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome.

Demiryay E, Yaylali V, Cetin EN, Yildirim C.

Eye Contact Lens. 2011 Sep;37(5):312-5. doi: 10.1097/ICL.0b013e31822563be.

PMID:
21792057
3.

Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome.

Yoon KC, Heo H, Im SK, You IC, Kim YH, Park YG.

Am J Ophthalmol. 2007 Jul;144(1):86-92. Epub 2007 May 9.

PMID:
17493572
4.

Efficacy of topical cyclosporine A in the treatment of severe trachomatous dry eye.

Guzey M, Karaman SK, Satici A, Ozardali I, Sezer S, Bozkurt O.

Clin Experiment Ophthalmol. 2009 Aug;37(6):541-9. doi: 10.1111/j.1442-9071.2009.02090.x.

PMID:
19702702
5.

Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production.

Pflugfelder SC, De Paiva CS, Villarreal AL, Stern ME.

Cornea. 2008 Jan;27(1):64-9. doi: 10.1097/ICO.0b013e318158f6dc.

PMID:
18245969
6.

Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.

Toker E, Asfuro─člu E.

Cornea. 2010 Feb;29(2):133-40. doi: 10.1097/ICO.0b013e3181acf68d.

PMID:
19966564
7.

Autologous serum eye drops for dry eye after LASIK.

Noda-Tsuruya T, Asano-Kato N, Toda I, Tsubota K.

J Refract Surg. 2006 Jan-Feb;22(1):61-6.

PMID:
16447938
8.
9.

Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.

Wang Y, Ogawa Y, Dogru M, Kawai M, Tatematsu Y, Uchino M, Okada N, Igarashi A, Kujira A, Fujishima H, Okamoto S, Shimazaki J, Tsubota K.

Bone Marrow Transplant. 2008 Feb;41(3):293-302. Epub 2007 Nov 5.

PMID:
17982500
10.

Short term effects of topical cyclosporine and viscoelastic on the ocular surfaces in patients with dry eye.

Moon JW, Lee HJ, Shin KC, Wee WR, Lee JH, Kim MK.

Korean J Ophthalmol. 2007 Dec;21(4):189-94.

11.
12.

Antioxidant and inflammatory cytokine in tears of patients with dry eye syndrome treated with preservative-free versus preserved eye drops.

Jee D, Park SH, Kim MS, Kim EC.

Invest Ophthalmol Vis Sci. 2014 Jul 3;55(8):5081-9. doi: 10.1167/iovs.14-14483.

PMID:
24994869
13.

The effect of decreasing the dosage of cyclosporine A 0.05% on dry eye disease after 1 year of twice-daily therapy.

Su MY, Perry HD, Barsam A, Perry AR, Donnenfeld ED, Wittpenn JR, D'Aversa G.

Cornea. 2011 Oct;30(10):1098-104. doi: 10.1097/ICO.0b013e318206caee.

PMID:
21407074
14.

Topical cyclosporine 0.05% for the prevention of dry eye disease progression.

Rao SN.

J Ocul Pharmacol Ther. 2010 Apr;26(2):157-64. doi: 10.1089/jop.2009.0091.

PMID:
20415623
15.

Reversibility of dry eye deceleration after topical cyclosporine 0.05% withdrawal.

Rao SN.

J Ocul Pharmacol Ther. 2011 Dec;27(6):603-9. doi: 10.1089/jop.2011.0073. Epub 2011 Oct 14.

PMID:
21999340
17.
19.

Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group.

Sall K, Stevenson OD, Mundorf TK, Reis BL.

Ophthalmology. 2000 Apr;107(4):631-9. Erratum in: Ophthalmology 2000 Jul;107(7):1220.

PMID:
10768324
20.

Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness.

Benelli U, Nardi M, Posarelli C, Albert TG.

Cont Lens Anterior Eye. 2010 Apr;33(2):61-7. doi: 10.1016/j.clae.2010.01.003. Epub 2010 Feb 12.

PMID:
20153684
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk